{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:12Z","timestamp":1786437012472,"version":"build-2736575974"},"reference-count":94,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"1","funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/31\/B\/NZ5\/02735"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/02735"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Overweight, obesity, and metabolic dysfunction-associated fatty liver disease (MASLD) are increasingly prevalent in adolescents and are linked to alterations in the gut\u2013liver axis. Gut microbiota may contribute to early metabolic disturbances preceding overt disease.\n                    <jats:bold>Objective:<\/jats:bold>\n                    To compare gut microbiota composition and fecal metabolite profiles, including short-chain fatty acids (SCFAs) and amino acids (AAs), between adolescents with overweight\/obesity and normal-weight peers, and to evaluate differences associated with hepatic steatosis assessed by FibroScan-controlled attenuation parameter (CAP). Of 111 participants aged 13 to 17 years, 83 and 28 represented the study group with overweight or obesity and normal-weight control group, respectively. Hepatic steatosis consistent with MASLD was defined as CAP \u2265250 dB\/m. Gut microbiota was assessed by 16S ribosomal RNA (rRNA) sequencing and fecal metabolites by gas chromatography\u2013mass spectrometry (GC-MS).\n                    <jats:bold>Results:<\/jats:bold>\n                    Adolescents with overweight\/obesity showed impaired metabolic profiles compared with controls, while overall microbial \u03b1 and \u03b2 diversity did not differ between groups. Differences were observed in the relative abundance of several bacterial genera, including depletion of\n                    <jats:italic toggle=\"yes\">Lactobacillus<\/jats:italic>\n                    . Fecal concentrations of most AAs were significantly elevated in the overweight\/obesity group, whereas SCFA levels were unchanged. CAP-based stratification revealed that hepatic steatosis was associated with differences in richness-related \u03b1-diversity indices without \u03b2-diversity separation. Adolescents with fatty liver exhibited a distinct microbial signature involving low-abundance taxa and higher fecal acetate and butyrate levels.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Adolescents with overweight\/obesity and fatty liver display subtle but biologically relevant alterations in gut microbiota composition and fecal metabolite profiles despite preserved global microbial diversity. Early metabolic impairment appears to be associated with changes in specific bacterial taxa and AA metabolism rather than generalized dysbiosis.\n                  <\/jats:p>","DOI":"10.34133\/csbj.0136","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:05:22Z","timestamp":1779797122000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Gut Microbiota\u2013Metabolite Alterations Associated with Early Metabolic Dysfunction and Hepatic Steatosis in Adolescents"],"prefix":"10.34133","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4036-3191","authenticated-orcid":false,"given":"Natalia","family":"Zeber-Lubecka","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, 02-781 Warsaw, Poland."},{"name":"Department of Experimental Oncology, Laboratory of Cancer Metabolism, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-1837","authenticated-orcid":false,"given":"Pawe\u0142","family":"Czarnowski","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, Laboratory of Cancer Metabolism, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ziemska-Legi\u0119cka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, 02-781 Warsaw, Poland."},{"name":"Department of Experimental Oncology, Laboratory of Cancer Metabolism, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-8894","authenticated-orcid":false,"given":"Aldona","family":"Wierzbicka-Ruci\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Ja\u0144czyk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutrition Disorders, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Micha\u0142kiewicz","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Clinical Immunology, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5134-8643","authenticated-orcid":false,"given":"\u0141ukasz","family":"Obrycki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Transplantation and Hypertension, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieczys\u0142aw","family":"Litwin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kidney Transplantation and Hypertension, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Mikula","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, Laboratory of Cancer Metabolism, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Socha","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutrition Disorders, The Children\u2019s Memorial Health Institute, 04-730 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, 02-781 Warsaw, Poland."},{"name":"Department of Experimental Oncology, Laboratory of Cancer Metabolism, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"10","key":"e_1_3_4_2_2","first-page":"14","article-title":"High prevalence of metabolic-associated fatty liver disease (MAFLD) in children and adolescents with severe obesity","author":"Mierzwa M","year":"2025","unstructured":"Mierzwa M, Malczyk \u017b, Bik-Multanowski M, Brandt-Heunemann S, Flehmig B, Ma\u0142ecka-Tendera E, Mazur A, Petriczko E, Ranke MB, Wabitsch M, et al. High prevalence of metabolic-associated fatty liver disease (MAFLD) in children and adolescents with severe obesity. J Clin Med. 2025;14,(10): 3565.","journal-title":"J Clin Med"},{"key":"e_1_3_4_3_2","unstructured":"WHO Regional Office for Europe. WHO European Childhood Obesity Surveillance Initiative (COSI): Report on the sixth round of data collection 2022\u20132024. Copenhagen (Denmark): WHO Regional Office for Europe; 2025."},{"key":"e_1_3_4_4_2","unstructured":"Obesity and overweight. [accessed 18 Mar 2026] https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.obmed.2025.100613","article-title":"Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health","volume":"55","author":"Oladipupo SO","year":"2025","unstructured":"Oladipupo SO, Ezenabor EH, Ojo AB, Ogunlakin AD, Ojo OA. Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health. Obesity Med. 2025;55: Article 100613.","journal-title":"Obesity Med"},{"issue":"5","key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jpn3.12156","article-title":"Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature","volume":"78","author":"European Society for Pediatric Gastroenterology","year":"2024","unstructured":"European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Association for the Study of the Liver (EASL), North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), Latin-American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (LASPGHAN), Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN), Pan Arab Society for Pediatric Gastroenterology and Nutrition (PASPGHAN), Commonwealth Association of Paediatric Gastroenterology & Nutrition (CAPGAN), Federation of International Societies of Pediatric Hepatology, Gastroenterology and Nutrition (FISPGHAN). Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature. J Pediatr Gastroenterol Nutr. 2024;78(5):1190\u20131196.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"e_1_3_4_7_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis","volume":"10","author":"Anderson EL","year":"2015","unstructured":"Anderson EL, Howe LD, Jones HE, Higgins JPT, Lawlor DA, Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLOS ONE. 2015;10(10): Article e0140908.","journal-title":"PLOS ONE"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13312-024-3290-1","article-title":"Practice recommendations for metabolic dysfunction-associated steatotic liver disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN)","volume":"61","author":"Sood V","year":"2024","unstructured":"Sood V, Alam S, Nagral A, Srivastava A, Deshmukh A, Bavdekar A, Acharyya BC, Geetha SM, Gupte G, Bhatia I, et al. Practice recommendations for metabolic dysfunction-associated steatotic liver disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN). Indian Pediatr. 2024;61:919\u2013934.","journal-title":"Indian Pediatr"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12916-024-03744-x","article-title":"Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: A systematic review with meta-analysis and bibliometric analysis","volume":"22","author":"Oma\u00f1a-Guzm\u00e1n I","year":"2024","unstructured":"Oma\u00f1a-Guzm\u00e1n I, Rosas-Diaz M, Mart\u00ednez-L\u00f3pez YE, Perez-Navarro LM, Diaz-Badillo A, Alanis A, Bustamante A, Castillo-Ruiz O, Toro-Cisneros ND, Esquivel-Hernandez DA, et al. Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: A systematic review with meta-analysis and bibliometric analysis. BMC Med. 2024;22:548.","journal-title":"BMC Med"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"169","author":"Younossi ZM","year":"2025","unstructured":"Younossi ZM, Zelber-Sagi S, Lazarus JV, Wong VW-S, Yilmaz Y, Duseja A, Eguchi Y, Castera L, Pessoa MG, Oliveira CP, et al. Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis. Gastroenterology. 2025;169:1017\u20131032.e2.","journal-title":"Gastroenterology"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi ZM","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u2013S50.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"e_1_3_4_12_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0324483","article-title":"Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis","volume":"20","author":"Boushehri YG","year":"2025","unstructured":"Boushehri YG, Meymanatabadi Z, Tanha AE, Azami P, Alaei M, Alamdari AA, Momtazi H, Moezzi ND, Habibzadeh A, Khanmohammadi S. Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis. PLOS ONE. 2025;20(8): Article e0324483.","journal-title":"PLOS ONE"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1186\/s12889-024-19378-w","article-title":"Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: A systematic review and meta-analysis","volume":"24","author":"Jamil A","year":"2024","unstructured":"Jamil A, Chivese T, Elshaikh U, Sendall M. Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: A systematic review and meta-analysis. BMC Public Health. 2024;24:2701.","journal-title":"BMC Public Health"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3350\/cmh.2025.0718","article-title":"Pediatric metabolic dysfunction-associated steatotic liver disease and the gut microbiome: From research landscape to targeted modulation","volume":"32","author":"Jiang L","year":"2026","unstructured":"Jiang L, Du L-D, Zeng J, Chu H-K, Peng Z, Fan J-G. Pediatric metabolic dysfunction-associated steatotic liver disease and the gut microbiome: From research landscape to targeted modulation. Clin Mol Hepatol. 2026;32:53\u201368.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"e_1_3_4_15_2","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70137","article-title":"Consensus statement on metabolic dysfunction-associated steatotic liver disease in children and adolescents from the joint TASL-TSPGHAN expert committee","volume":"9","author":"Lin Y-C","year":"2025","unstructured":"Lin Y-C, Liao F-M, Chao H-C, Chen A-C, Jeng Y-M, Lin C-C, Tiao M-M, Yang Y-J, Yeung C-Y, Chen H-L, et al. Consensus statement on metabolic dysfunction-associated steatotic liver disease in children and adolescents from the joint TASL-TSPGHAN expert committee. JGH Open. 2025;9(6): Article e70137.","journal-title":"JGH Open"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"1159148","DOI":"10.3389\/fendo.2023.1159148","article-title":"Investigating causal associations among gut microbiota, metabolites, and liver diseases: A Mendelian randomization study","volume":"14","author":"Zhang L","year":"2023","unstructured":"Zhang L, Zi L, Kuang T, Wang K, Qiu Z, Wu Z, Liu L, Liu R, Wang P, Wang W. Investigating causal associations among gut microbiota, metabolites, and liver diseases: A Mendelian randomization study. Front Endocrinol. 2023;14:1159148.","journal-title":"Front Endocrinol"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: A systematic review and meta-analysis","volume":"20","author":"Li F","year":"2021","unstructured":"Li F, Ye J, Shao C, Zhong B. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: A systematic review and meta-analysis. Lipids Health Dis. 2021;20:22.","journal-title":"Lipids Health Dis"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18754-5"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13646","article-title":"Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"25","author":"Su X","year":"2024","unstructured":"Su X, Chen S, Liu J, Feng Y, Han E, Hao X, Liao M, Cai J, Zhang S, Niu J, et al. Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Obes Rev. 2024;25: Article e13646.","journal-title":"Obes Rev"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000042016","article-title":"The accuracy of FibroScan, FIB-4, and nonalcoholic fatty liver disease fibrosis score in predicting biopsy-defined fibrosis and steatosis across all fibrosis stages in patients with metabolic dysfunction associated steatotic liver disease","volume":"104","author":"Thallapureddy K","year":"2025","unstructured":"Thallapureddy K, Twitchell D, Ott K, Pedicone LD, Owo C, Kumar N, Gelfond J, Shankar N, Goros M, Kwok D, et al. The accuracy of FibroScan, FIB-4, and nonalcoholic fatty liver disease fibrosis score in predicting biopsy-defined fibrosis and steatosis across all fibrosis stages in patients with metabolic dysfunction associated steatotic liver disease. Medicine. 2025;104: Article e42016.","journal-title":"Medicine"},{"issue":"3","key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/diagnostics15030299","article-title":"Evaluating pediatric NAFLD with controlled attenuation parameter: A comprehensive narrative review","volume":"15","author":"Arteaga I","year":"2025","unstructured":"Arteaga I, Chac\u00f3n C, Mart\u00ednez-Escud\u00e9 A, Rojano IR, Diez-Fadrique G, Carmona-Cervell\u00f3 M, Tor\u00e1n-Monserrat P. Evaluating pediatric NAFLD with controlled attenuation parameter: A comprehensive narrative review. Diagnostics. 2025;15(3):299.","journal-title":"Diagnostics"},{"issue":"11","key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): A novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso M","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V. Controlled attenuation parameter (CAP): A novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825\u20131835.","journal-title":"Ultrasound Med Biol"},{"issue":"7","key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/nu16070917","article-title":"Effects of soluble dextrin fiber from potato starch on body weight and associated gut dysbiosis are evident in Western diet-fed mice but not in overweight\/obese children","volume":"16","author":"Czarnowski P","year":"2024","unstructured":"Czarnowski P, Ba\u0142abas A, Ku\u0142aga Z, Kulecka M, Goryca K, Py\u015bniak K, Unrug-Bielawska K, Kluska A, Bagi\u0144ska-Drabiuk K, G\u0142owienka-Stodolak M, et al. Effects of soluble dextrin fiber from potato starch on body weight and associated gut dysbiosis are evident in Western diet-fed mice but not in overweight\/obese children. Nutrients. 2024;16(7):917.","journal-title":"Nutrients"},{"issue":"9","key":"e_1_3_4_24_2","first-page":"14","article-title":"Lifetime changes in gut microbiota and metabolite composition in high-fat diet-induced obesity in apolipoprotein A-IV gene knockout mice","author":"Zeber-Lubecka N","year":"2025","unstructured":"Zeber-Lubecka N, Kulecka M, Balabas A, Czarnowski P, Py\u015bniak K, D\u0105browska M, Ostrowski J, Hennig EE. Lifetime changes in gut microbiota and metabolite composition in high-fat diet-induced obesity in apolipoprotein A-IV gene knockout mice. Biology. 2025;14, (9): 1278.","journal-title":"Biology"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081904"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","unstructured":"Callahan BJ McMurdie PJ Rosen MJ Han AW Johnson AJA Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u2013583.","DOI":"10.1038\/nmeth.3869"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02224"},{"key":"e_1_3_4_28_2","unstructured":"R: The R project for statistical computing. [accessed 18 Mar 2026] https:\/\/www.r-project.org\/"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","unstructured":"Oksanen J Simpson GL Blanchet FG Kindt R Legendre P Minchin PR O\u2019Hara B Solymos P Stevens MHH Szoecs E et\u00a0al. Vegan: Community ecology package. 2001.","DOI":"10.32614\/CRAN.package.vegan"},{"key":"e_1_3_4_30_2","first-page":"32","article-title":"A new method for non-parametric multivariate analysis of variance","volume":"26","author":"Anderson MJ","year":"2001","unstructured":"Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 2001;26:32\u201346.","journal-title":"Austral Ecol"},{"key":"e_1_3_4_31_2","first-page":"265","article-title":"Nonparametric estimation of the number of classes in a population","volume":"11","author":"Chao A","year":"1984","unstructured":"Chao A. Nonparametric estimation of the number of classes in a population. Scand J Stat. 1984;11:265\u2013270.","journal-title":"Scand J Stat"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.2307\/1411"},{"issue":"3","key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","article-title":"A mathematical theory of communication","volume":"27","author":"Shannon CE","year":"1948","unstructured":"Shannon CE. A mathematical theory of communication. Bell Syst Tech J. 1948;27(3):379\u2013423.","journal-title":"Bell Syst Tech J"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/163688a0"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17041-7"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"issue":"4","key":"e_1_3_4_38_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061217","article-title":"Phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data","volume":"8","author":"McMurdie PJ","year":"2013","unstructured":"McMurdie PJ, Holmes S. Phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLOS ONE. 2013;8(4): Article e61217.","journal-title":"PLOS ONE"},{"key":"e_1_3_4_39_2","unstructured":"Introduction to the microbiome R package. [accessed 18 Mar 2026] https:\/\/microbiome.github.io\/tutorials\/"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","unstructured":"Wickham H. Data analysis. In: Wickham H editor. ggplot2: Elegant graphics for data analysis. Cham: Springer International Publishing; 2016. p. 189\u2013201.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"e_1_3_4_41_2","unstructured":"Kassambara A. kassambara\/ggpubr. 2026."},{"issue":"5","key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2020.06.036","article-title":"Reply to: Correspondence on \u201cA new definition for metabolic associated fatty liver disease: An international expert consensus statement\u201d: MAFLD: Moving from a concept to practice","volume":"73","author":"Eslam M","year":"2020","unstructured":"Eslam M, George J. Reply to: Correspondence on \u201cA new definition for metabolic associated fatty liver disease: An international expert consensus statement\u201d: MAFLD: Moving from a concept to practice. J Hepatol. 2020;73(5):1268\u20131269.","journal-title":"J Hepatol"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu14010012"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10517-024-06073-4","article-title":"Alpha diversity indices as indicators of the variability of gut microbiota in obese adolescents of different ethnicities","volume":"176","author":"Klimenko ES","year":"2024","unstructured":"Klimenko ES, Belkova NL, Rychkova LV, Darenskaya MA, Tugarinova OA, Semenova NV, Savinova YS, Bugun OV, Balzhirova DB, Kolesnikova LI. Alpha diversity indices as indicators of the variability of gut microbiota in obese adolescents of different ethnicities. Bull Exp Biol Med. 2024;176:591\u2013594.","journal-title":"Bull Exp Biol Med"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu17142320"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: An international expert consensus statement","volume":"6","author":"Eslam M","year":"2021","unstructured":"Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, Marcus C, Lee WS, Kelly D, Porta G, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: An international expert consensus statement. Lancet Gastroenterol Hepatol. 2021;6:864\u2013873.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.25259\/IJCDW_2_2024","article-title":"Do hepatic fibrosis and steatosis measured by hepatic transient elastography (FibroScan) predict cardiovascular risk in patients with non-alcoholic fatty liver disease: An observational cross-sectional study","volume":"9","author":"Goyal P","year":"2024","unstructured":"Goyal P, Chopra R, Goyal O. Do hepatic fibrosis and steatosis measured by hepatic transient elastography (FibroScan) predict cardiovascular risk in patients with non-alcoholic fatty liver disease: An observational cross-sectional study. Indian J Cardiovasc Dis Women. 2024;9:66\u201373.","journal-title":"Indian J Cardiovasc Dis Women"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajg.2023.08.003","article-title":"Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis","volume":"24","author":"Xu X","year":"2023","unstructured":"Xu X, Jin J, Liu Y. Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Arab J Gastroenterol. 2023;24:189\u2013197.","journal-title":"Arab J Gastroenterol"},{"issue":"50","key":"e_1_3_4_49_2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013636","article-title":"Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting","volume":"97","author":"Ahn SB","year":"2018","unstructured":"Ahn SB, Jun DW, Kang B-K, Kim M, Chang M, Nam E. Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting. Medicine. 2018;97(50): Article e13636.","journal-title":"Medicine"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"51","author":"Cao Y","year":"2022","unstructured":"Cao Y, Xiang L, Qi F, Zhang Y, Chen Y, Zhou X. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. EClinicalMedicine. 2022;51: Article 101547.","journal-title":"EClinicalMedicine"},{"key":"e_1_3_4_51_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-019-0961-9","article-title":"Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"19","author":"Pu K","year":"2019","unstructured":"Pu K, Wang Y, Bai S, Wei H, Zhou Y, Fan J, Qiao L. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: A systematic review and meta-analysis. BMC Gastroenterol. 2019;19:51.","journal-title":"BMC Gastroenterol"},{"key":"e_1_3_4_52_2","doi-asserted-by":"crossref","first-page":"6662760","DOI":"10.1155\/2021\/6662760","article-title":"Controlled attenuation parameter for quantification of steatosis: Which cut-offs to use?","volume":"2021","author":"Sirli R","year":"2021","unstructured":"Sirli R, Sporea I. Controlled attenuation parameter for quantification of steatosis: Which cut-offs to use? Can J Gastroenterol Hepatol. 2021;2021:6662760.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"12","key":"e_1_3_4_53_2","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/diagnostics11122341","article-title":"The prevalence of liver steatosis and fibrosis assessed by vibration-controlled transient elastography and controlled attenuation parameter in apparently healthy Romanian medical students","volume":"11","author":"Nastasa R","year":"2021","unstructured":"Nastasa R, Stanciu C, Zenovia S, Singeap A-M, Cojocariu C, Sfarti C, Girleanu I, Chiriac S, Cuciureanu T, Huiban L, et al. The prevalence of liver steatosis and fibrosis assessed by vibration-controlled transient elastography and controlled attenuation parameter in apparently healthy Romanian medical students. Diagnostics. 2021;11(12):2341.","journal-title":"Diagnostics"},{"issue":"4","key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/diagnostics13040788","article-title":"How to identify advanced fibrosis in adult patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) using ultrasound elastography\u2014a review of the literature and proposed multistep approach","volume":"13","author":"Taru M-G","year":"2023","unstructured":"Taru M-G, Neamti L, Taru V, Procopciuc LM, Procopet B, Lupsor-Platon M. How to identify advanced fibrosis in adult patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) using ultrasound elastography\u2014a review of the literature and proposed multistep approach. Diagnostics. 2023;13(4):788.","journal-title":"Diagnostics"},{"issue":"3","key":"e_1_3_4_55_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/diagnostics15030299","article-title":"Evaluating pediatric NAFLD with controlled attenuation parameter: A comprehensive narrative review","volume":"15","author":"Arteaga I","year":"2025","unstructured":"Arteaga I, Chac\u00f3n C, Mart\u00ednez-Escud\u00e9 A, Ruiz Rojano I, Diez Fadrique GS, Carmona Cervell\u00f3 M, Tor\u00e1n-Monserrat P. Evaluating pediatric NAFLD with controlled attenuation parameter: A comprehensive narrative review. Diagnostics. 2025;15(3):229.","journal-title":"Diagnostics"},{"key":"e_1_3_4_56_2","doi-asserted-by":"crossref","first-page":"fuad014","DOI":"10.1093\/femsre\/fuad014","article-title":"Ruminococcus gnavus: Friend or foe for human health","volume":"47","author":"Crost EH","year":"2023","unstructured":"Crost EH, Coletto E, Bell A, Juge N. Ruminococcus gnavus: Friend or foe for human health. FEMS Microbiol Rev. 2023;47:fuad014.","journal-title":"FEMS Microbiol Rev"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2017.1406584","article-title":"Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women","volume":"9","author":"Gomez-Arango LF","year":"2018","unstructured":"Gomez-Arango LF, Barrett HL, Wilkinson SA, Callaway LK, McIntyre HD, Morrison M, Nitert MD. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women. Gut Microbes. 2018;9:189\u2013201.","journal-title":"Gut Microbes"},{"key":"e_1_3_4_58_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1880221","article-title":"Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly","volume":"13","author":"Tavella T","year":"2021","unstructured":"Tavella T, Rampelli S, Guidarelli G, Bazzocchi A, Gasperini C, Pujos-Guillot E, Comte B, Barone M, Biagi E, Candela M, et al. Elevated gut microbiome abundance of Christensenellaceae, Porphyromonadaceae and Rikenellaceae is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly. Gut Microbes. 2021;13:1\u201319.","journal-title":"Gut Microbes"},{"key":"e_1_3_4_59_2","doi-asserted-by":"crossref","first-page":"700058","DOI":"10.3389\/fnut.2021.700058","article-title":"Role of the gut microbiota in regulating non-alcoholic fatty liver disease in children and adolescents","volume":"8","author":"Tokuhara D","year":"2021","unstructured":"Tokuhara D. Role of the gut microbiota in regulating non-alcoholic fatty liver disease in children and adolescents. Front Nutr. 2021;8:700058.","journal-title":"Front Nutr"},{"issue":"3","key":"e_1_3_4_60_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/nu12030820","article-title":"Gut microbiota dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: A cross-sectional study in Taiwan","volume":"12","author":"Tsai M-C","year":"2020","unstructured":"Tsai M-C, Liu Y-Y, Lin C-C, Wang C-C, Wu Y-J, Yong C-C, Chen K-D, Chuah S-K, Yao C-C, Huang P-Y, et al. Gut microbiota dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: A cross-sectional study in Taiwan. Nutrients. 2020;12(3):820.","journal-title":"Nutrients"},{"issue":"3","key":"e_1_3_4_61_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213692","article-title":"Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects","volume":"14","author":"Yun Y","year":"2019","unstructured":"Yun Y, Kim H-N, Lee E-J, Ryu S, Chang Y, Shin H, Kim H-L, Kim T-H, Yoo K, Kim HY. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. PLOS ONE. 2019;14(3): Article e0213692.","journal-title":"PLOS ONE"},{"issue":"1","key":"e_1_3_4_62_2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41467-022-28034-z","article-title":"Microbiome differential abundance methods produce different results across 38 datasets","volume":"13","author":"Nearing JT","year":"2022","unstructured":"Nearing JT, Douglas GM, Hayes MG, MacDonald J, Desai DK, Allward N, Jones CM, Wright RJ, Dhanani AS, Comeau AM, et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat Commun. 2022;13(1):342.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_4_63_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13059-020-02104-1","article-title":"Assessment of statistical methods from single cell, bulk RNA-seq, and metagenomics applied to microbiome data","volume":"21","author":"Calgaro M","year":"2020","unstructured":"Calgaro M, Romualdi C, Waldron L, Risso D, Vitulo N. Assessment of statistical methods from single cell, bulk RNA-seq, and metagenomics applied to microbiome data. Genome Biol. 2020;21(1):191.","journal-title":"Genome Biol"},{"issue":"3","key":"e_1_3_4_64_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247378","article-title":"Stool metabolome-microbiota evaluation among children and adolescents with obesity, overweight, and normal-weight using 1H NMR and 16S rRNA gene profiling","volume":"16","author":"Jaimes JD","year":"2021","unstructured":"Jaimes JD, Slav\u00ed\u010dkov\u00e1 A, Hurych J, Cinek O, Nichols B, Vodol\u00e1nov\u00e1 L, \u010cern\u00fd K, Havl\u00edk J. Stool metabolome-microbiota evaluation among children and adolescents with obesity, overweight, and normal-weight using 1H NMR and 16S rRNA gene profiling. PLOS ONE. 2021;16(3): Article e0247378.","journal-title":"PLOS ONE"},{"key":"e_1_3_4_65_2","first-page":"717","article-title":"Human fecal metabolome reflects differences in body mass index, physical fitness, and blood lipoproteins in healthy older adults","volume":"11","author":"Cui M","year":"2021","unstructured":"Cui M, Trimigno A, Castro-Mej\u00eda JL, Reitelseder S, B\u00fclow J, Bechsh\u00f8ft RL, Nielsen DS, Holm L, Engelsen SB, Khakimov B. Human fecal metabolome reflects differences in body mass index, physical fitness, and blood lipoproteins in healthy older adults. Meta. 2021;11:717.","journal-title":"Meta"},{"key":"e_1_3_4_66_2","doi-asserted-by":"crossref","first-page":"1657839","DOI":"10.3389\/fmicb.2025.1657839","article-title":"Gut microbiome and fecal metabolite profiles in obese school-aged children from northern Thailand","volume":"16","author":"Therdtatha P","year":"2025","unstructured":"Therdtatha P, Gruneck L, Nachalam P, Jinatham V, Saninjuk K, Nakayama J, Popluechai S. Gut microbiome and fecal metabolite profiles in obese school-aged children from northern Thailand. Front Microbiol. 2025;16:1657839.","journal-title":"Front Microbiol"},{"key":"e_1_3_4_67_2","doi-asserted-by":"crossref","first-page":"1224982","DOI":"10.3389\/fmolb.2023.1224982","article-title":"Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes","volume":"10","author":"Patra D","year":"2023","unstructured":"Patra D, Banerjee D, Ramprasad P, Roy S, Pal D, Dasgupta S. Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes. Front Mol Biosci. 2023;10:1224982.","journal-title":"Front Mol Biosci"},{"key":"e_1_3_4_68_2","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8317","article-title":"Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing","volume":"8","author":"Chen X","year":"2020","unstructured":"Chen X, Sun H, Jiang F, Shen Y, Li X, Hu X, Shen X, Wei P. Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing. PeerJ. 2020;8: Article e8317.","journal-title":"PeerJ"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00503-6"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab256"},{"issue":"15","key":"e_1_3_4_71_2","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.3390\/ijms26157129","article-title":"Current data on the role of amino acids in the management of obesity in children and adolescents","volume":"26","author":"Zamosteanu D","year":"2025","unstructured":"Zamosteanu D, Filip N, Trandafir LM, \u0162arc\u0103 E, Pertea M, Bordeianu G, Bernic J, Heredea AM, Cojocaru E. Current data on the role of amino acids in the management of obesity in children and adolescents. Int J Mol Sci. 2025;26(15):7129.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"e_1_3_4_72_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11306-025-02279-3","article-title":"Faecal amino acids stability: Investigating optimal sampling conditions for analysis","volume":"21","author":"Opperman RCM","year":"2025","unstructured":"Opperman RCM, Vermeer E, Bosch S, de Meij TGJ, de Boer NKH, Struys EA. Faecal amino acids stability: Investigating optimal sampling conditions for analysis. Metabolomics. 2025;21(4):81.","journal-title":"Metabolomics"},{"issue":"7","key":"e_1_3_4_73_2","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.3390\/molecules28073269","article-title":"An overview on fecal profiles of amino acids and related amino-derived compounds in children with autism spectrum disorder in Tunisia","volume":"28","author":"Chamtouri M","year":"2023","unstructured":"Chamtouri M, Merghni A, Salazar N, Redruello B, Gaddour N, Mastouri M, Arboleya S, de los Reyes-Gavil\u00e1n CG. An overview on fecal profiles of amino acids and related amino-derived compounds in children with autism spectrum disorder in Tunisia. Molecules. 2023;28(7):3269.","journal-title":"Molecules"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158026"},{"key":"e_1_3_4_75_2","doi-asserted-by":"crossref","first-page":"994930","DOI":"10.3389\/fendo.2022.994930","article-title":"Roles of gut microbiota and metabolites in overweight and obesity of children","volume":"13","author":"Zhang S","year":"2022","unstructured":"Zhang S, Dang Y. Roles of gut microbiota and metabolites in overweight and obesity of children. Front Endocrinol. 2022;13:994930.","journal-title":"Front Endocrinol"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.03.025"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0704-8"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0188-7"},{"key":"e_1_3_4_79_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1574-6941.1998.tb00508.x","article-title":"Polysaccharide degradation by human intestinal bacteria during growth under multi-substrate limiting conditions in a three-stage continuous culture system","volume":"26","author":"Macfarlane S","year":"1998","unstructured":"Macfarlane S, Quigley ME, Hopkins MJ, Newton DF, Macfarlane GT. Polysaccharide degradation by human intestinal bacteria during growth under multi-substrate limiting conditions in a three-stage continuous culture system. FEMS Microbiol Ecol. 1998;26:231\u2013243.","journal-title":"FEMS Microbiol Ecol"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.10.024"},{"key":"e_1_3_4_81_2","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.3389\/fmicb.2018.03196","article-title":"Synergistic impacts of organic acids and pH on growth of Pseudomonas aeruginosa: A comparison of parametric and Bayesian non-parametric methods to model growth","volume":"9","author":"Bushell FML","year":"2019","unstructured":"Bushell FML, Tonner PD, Jabbari S, Schmid AK, Lund PA. Synergistic impacts of organic acids and pH on growth of Pseudomonas aeruginosa: A comparison of parametric and Bayesian non-parametric methods to model growth. Front Microbiol. 2019;9:3196.","journal-title":"Front Microbiol"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15020272"},{"key":"e_1_3_4_83_2","first-page":"316","article-title":"Mechanistic links between the gut microbiome and longevity therapeutics","volume":"14","author":"Garzon-Escamilla N","year":"2026","unstructured":"Garzon-Escamilla N, Medina-Cardena M, Roy P, Trent J, Jamous J, Somesan Y, Denslow SJ. Mechanistic links between the gut microbiome and longevity therapeutics. Biomedicine. 2026;14:316.","journal-title":"Biomedicine"},{"issue":"3","key":"e_1_3_4_84_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.21307\/pjm-2018-041","article-title":"Bacterial microbiota and fatty acids in the faeces of overweight and obese children","volume":"67","author":"Barczy\u0144ska R","year":"2018","unstructured":"Barczy\u0144ska R, Litwin M, Sli\u017cewska K, Szalecki M, Berdowska A, Bandurska K, Libudzisz Z, Kapu\u015bniak J. Bacterial microbiota and fatty acids in the faeces of overweight and obese children. Pol J Microbiol. 2018;67(3):339\u2013345.","journal-title":"Pol J Microbiol"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2011.8"},{"issue":"6","key":"e_1_3_4_86_2","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12750","article-title":"Cross-sectional comparisons of gut microbiome and short-chain fatty acid levels among children with varied weight classifications","volume":"16","author":"Gyarmati P","year":"2021","unstructured":"Gyarmati P, Song Y, Dotimas J, Yoshiba G, Christison A. Cross-sectional comparisons of gut microbiome and short-chain fatty acid levels among children with varied weight classifications. Pediatr Obes. 2021;16(6): Article e12750.","journal-title":"Pediatr Obes"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/1462-2920.13463"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3143-0"},{"issue":"8","key":"e_1_3_4_89_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender R","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLOS Biol. 2016;14(8): Article e1002533.","journal-title":"PLOS Biol"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040293"},{"key":"e_1_3_4_91_2","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3389\/fmicb.2019.02346","article-title":"Cross-regional view of functional and taxonomic microbiota composition in obesity and post-obesity treatment shows country specific microbial contribution","volume":"10","author":"Medina DA","year":"2019","unstructured":"Medina DA, Li T, Thomson P, Artacho A, P\u00e9rez-Brocal V, Moya A. Cross-regional view of functional and taxonomic microbiota composition in obesity and post-obesity treatment shows country specific microbial contribution. Front Microbiol. 2019;10:2346.","journal-title":"Front Microbiol"},{"key":"e_1_3_4_92_2","unstructured":"Oldfield M. Unequal sample sizes and the use of larger control groups pertaining to power of a study. Dstl. 2016;1."},{"issue":"1","key":"e_1_3_4_93_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13104-017-2768-5","article-title":"A comparative study of the impacts of unbalanced sample sizes on the four synthesized methods of meta-analytic structural equation modeling","volume":"10","author":"Alamolhoda M","year":"2017","unstructured":"Alamolhoda M, Ayatollahi SMT, Bagheri Z. A comparative study of the impacts of unbalanced sample sizes on the four synthesized methods of meta-analytic structural equation modeling. BMC Res Notes. 2017;10(1):446.","journal-title":"BMC Res Notes."},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu12103197"},{"key":"e_1_3_4_95_2","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.896348","article-title":"Gut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health","volume":"9","author":"Huda MN","year":"2022","unstructured":"Huda MN, Salvador AC, Barrington WT, Gacasan CA, D\u2019Souza EM, Deus Ramirez L, Threadgill DW, Bennett BJ. Gut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health. Front Nutr. 2022;9: Article 896348.","journal-title":"Front Nutr"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/csbj.0136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:00:30Z","timestamp":1786435230000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/csbj.0136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.34133\/csbj.0136"],"URL":"https:\/\/doi.org\/10.34133\/csbj.0136","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]},"assertion":[{"value":"2026-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0136"}}